Tine Graakjær Larsen

Tine Graakjær Larsen

Auto-generated profile, based on publicly available information

Tine Graakjær Larsen

Statens Serum Institut

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 September 2023 in Eurosurveillance
Verified
Journal Article
Open access
MRMorten Rasmussen
Morten Rasmussen
FMFrederik Trier Møller
Frederik Trier Møller
VGVithiagaran Gunalan
Vithiagaran Gunalan
SBSharmin Baig
Sharmin Baig
MBMarc Bennedbæk
Marc Bennedbæk
PJPikka Jokelainen
Pikka Jokelainen
We describe 10 cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant BA.2.86 detected in Denmark, including molecular characteristics and results from wastewater surveillance that indicate that the variant is circulating in the country at a low level. This new variant with many spike gene mutations was classified as a variant under monitoring by the World Health Organization on 17 August 2023. Further global monitoring of COVID-19, BA.2.86 and other SARS-CoV-2 variants is highly warranted.

1 January 2019 in Placenta
Verified
Journal Article
Closed access
TLTine Graakjær Larsen
Tine Graakjær Larsen
RHRinat Hackmon
Rinat Hackmon
DGDaniel E. Geraghty
Daniel E. Geraghty
THThomas Vauvert Faurschou Hviid
Thomas Vauvert Faurschou Hviid

24 July 2025 in Emerging Microbes & Infections
Verified
Journal Article
Open access
TLTine Graakjær Larsen
Tine Graakjær Larsen
SESteen Ethelberg
Steen Ethelberg
HNHans Linde Nielsen
Hans Linde Nielsen
GHGitte Nyvang Hartmeyer
Gitte Nyvang Hartmeyer
LNLene Nielsen
Lene Nielsen
CSChristen Rune Stensvold
Christen Rune Stensvold
Human cryptosporidiosis, a diarrheal disease caused by Cryptosporidium species, has previously been considered rare in Denmark and primarily associated with travel abroad. The disease came under national surveillance in 2023. Here, we assess all cases identified in Denmark from 2010 to 2024, determine the species distribution, analyse trends in time and place, and relate the findings to recent changes in diagnostic methods. After 2021, the number of new cases increased substantially. This increase coincided with the adoption of gastrointestinal syndromic testing in several local hospitals. During seasonal peaks (August-October), Cryptosporidium was detected in the stool of >2% of patients tested. Infections predominantly occurred in individuals without known comorbidities, and hospitalization rates exceeded 10% in recent years. Co-infections with enteropathogenic bacteria were rare (6%), suggesting that Cryptosporidium alone was the causative agent in the patients. Most cases had no history of travel outside Denmark. Beyond C. parvum (56.9%), and C. hominis (11.3%), species of zoonotic relevance were implicated, involving typically C. mortiferum (2.5%), C. erinacei (0.8%), C. meleagridis (1.7%), and C. felis (1.2%). The transition from microscopy to high-throughput molecular diagnostic methods along with the testing of more patients, including those without recent travel history, has dramatically improved the detection of Cryptosporidium in stool samples in Denmark. Cryptosporidiosis appears to be a common and endemic disease in Denmark. The wide heterogeneity of infecting species suggests a number of transmission routes; these are yet to be uncovered. Cryptosporidiosis should be considered a common gastrointestinal infection by clinicians in Denmark and preventive measures should be prioritized.

25 March 2025 in Journal of Medical Virology
Verified
Journal Article
Open access
TLTine Graakjær Larsen
Tine Graakjær Larsen
JGJonathan R. Ginty
Jonathan R. Ginty
RJRandi Jessen
Randi Jessen
RNRuben Bjerregaard Nielsen
Ruben Bjerregaard Nielsen
AJAnders Jensen
Anders Jensen
FMFrederik Trier Møller
Frederik Trier Møller
This study presents findings captured in the first 1.5 years of the Virus Monitoring in Denmark (VMD) surveillance system. It describes trends in respiratory viruses, related symptoms, and participant demographics and behaviors. VMD used self‐swabbing and self‐reported symptoms to monitor respiratory viruses in the general population. Participants were recruited via digital invitations to a representative sample of the population or through workplaces. Symptomatic participants could self‐swab and register their samples and report their symptoms via a dedicated smartphone web app. With 30 627 participants and 12 642 samples analyzed, VMD had a broad demographic representation. SARS‐CoV‐2 was the most frequently detected virus, with positivity rates peaking at over 50% in late 2023. Participants commonly self‐swabbed because of fever, cough, and rhinorrhea, with influenza A linked to the highest median number of symptoms. Participants only provided samples after reaching a specific symptom threshold, and participation affected the health‐seeking behaviors and work attendance of a few individuals. VMD continuously provided real‐time insights into respiratory virus trends and symptomatology in the general non‐healthcare‐seeking population. Its accessibility – available to anyone with a Danish identification number, a smartphone, and an invitation – highlights its potential as a pandemic preparedness tool.

14 February 2023 in Travel Medicine and Infectious Disease
Verified
Journal Article
Open access
TLTine Graakjær Larsen
Tine Graakjær Larsen
JKJonas Kähler
Jonas Kähler
MLMarianne Lebbad
Marianne Lebbad
HAHuma Aftab
Huma Aftab
LMLuise Müller
Luise Müller
CSChristen Rune Stensvold
Christen Rune Stensvold